$LFCR News
Last published 1w ago
- 1w agoLFCRLIFECORE BIOMEDICAL, INC. \DE\ - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1mo agoLFCRLifecore Biomedical to Participate at Upcoming Industry ConferencesGlobeNewswireCHASKA, Minn., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"),
- 2mo agoLFCRLifecore Biomedical to Participate at CPHI Global ConferenceGlobeNewswireCHASKA, Minn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"),
- 2mo agoLFCRLifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical CompanyGlobeNewswire-- Significant New Program Positioned to Become One of Lifecore’s Largest Contracts -- -- Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Drug Product -- -- Program Expected
- 3mo agoLFCRQ2 2026 Lifecore Biomedical Earnings Conference Call - LIFECORE BIOMEDICAL INCEarnings Call TranscriptsGood morning, and thank you for joining LifeCorp Earnings Call for the second quarter and six months ended, June 30, 2026. During the call, all participants will be in listen-only mode. Now, I would like to turn the call
- 3mo agoLFCRQ2 2026 Lifecore Biomedical Earnings Conference Call - LIFECORE BIOMEDICAL INCEarnings Call TranscriptsGood morning, and thank you for joining LifeCorp Earnings Call for the second quarter and six months ended, June 30, 2026. During the call, all participants will be in listen-only mode. Now, I would like to turn the call
- 3mo agoLFCRLifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate UpdateGlobeNewswire-- Reaffirms 2026 Guidance -- -- Multiple New Business Wins, Adding Impactful Programs to Pipeline -- -- Cost Reduction and Productivity Enhancements Continue to Strengthen Organization -- Conference Call Today at
- 3mo agoLFCRLifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026GlobeNewswireCHASKA, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today
- 3mo agoLFCRLifecore Biomedical Signs Three New Customer AgreementsGlobeNewswire--Technology Transfer Agreement for Regenerative Medicine Late-Stage Development Program-- --Two Additional Agreements Supporting Early-Stage Programs Including Formulation and Development for a Global Medical
- 3mo agoLFCRLifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCHASKA, Minn., July 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore") a fully integrated injectables contract development and manufacturing organization ("CDMO"), today
- 4mo agoLFCRLifecore Biomedical Signs New Agreement with Global Pharmaceutical CompanyGlobeNewswire--Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Neurology Product-- --Seventh Addition to Lifecore's Late-Stage Pipeline in Seven Months-- CHASKA, Minn., June 15, 2026 (GLOBE
- 5mo agoLFCRLifecore Biomedical Signs Agreement with New Biopharmaceutical CustomerGlobeNewswire-- Agreement Calls for Tech Transfer in Preparation for Potential Commercial Manufacturing of Injectable Ophthalmic Product -- -- Sixth Addition to Late-Stage Pipeline in Seven Months -- CHASKA, Minn., June 02, 2026
- 5mo agoLFCRLifecore Biomedical to Participate in William Blair 46th Annual Growth Stock ConferenceGlobeNewswireCHASKA, Minn., May 21, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 6mo agoLFCRLifecore Biomedical to Participate at CDMO Live EuropeGlobeNewswireCHASKA, Minn., May 12, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 6mo agoLFCRQ1 2026 Lifecore Biomedical Earnings Conference CallLIFECORE BIOMEDICAL INCEarnings Call TranscriptsGood morning, and thank you for joining LifeCorps' earnings call for the first quarter ended March 31st, 2026. During the call, all participants will be in a listen-only mode. Now, I would like to turn the call over to S
- 6mo agoLFCRLifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate UpdateGlobeNewswire-- Reaffirms 2026 Guidance -- -- Signed Three New Commercial Site Transfer Programs in First Quarter 2026 -- -- Cost Containment Initiatives Continue to Drive Down Expenses -- Conference Call Today at 8:00am ET
- 6mo agoLFCRLifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026GlobeNewswireCHASKA, Minn., April 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 6mo agoLFCRLifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCHASKA, Minn., April 22, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore") a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 7mo agoLFCRLifecore Biomedical to Participate at 12th Annual American Biomanufacturing SummitGlobeNewswireCHASKA, Minn., April 08, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 7mo agoLFCRLifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCHASKA, Minn., March 26, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore") a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 7mo agoLFCRLifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical CustomerGlobeNewswire-- Site Transfer Agreement for the Manufacture of Commercially Marketed Product -- -- Second Agreement Supports the Expansion of Product Commercially Manufactured at Lifecore to a New Delivery System -- -- Fourth
- 8mo agoLFCRQ4 2025 Lifecore Biomedical Earnings Conference CallLIFECORE BIOMEDICAL INCEarnings Call TranscriptsGood day, and welcome to the LifeCorps Biomedical 4th Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer s
- 8mo agoLFCRLifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate UpdateGlobeNewswire-- Recorded Fourth Quarter Revenues of $35.7 Million and Transition Period Revenues of $75.5 Million -- -- Multiple New Programs Signed in Fourth Quarter 2025 Including Two Commercial Site Transfer Programs, for Total
- 8mo agoLFCRLifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual ForumGlobeNewswireCHASKA, Minn., March 10, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 8mo agoLFCRLifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026GlobeNewswireCHASKA, Minn., March 09, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 8mo agoLFCRLifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne TreatmentGlobeNewswireIndomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen™, its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture Drug Batches in
- 8mo agoLFCRLifecore Biomedical to Participate at DCAT Week 2026GlobeNewswireCHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that
- 9mo agoIBTALFCRMOHVRNSNotice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Varonis Systems, Inc. (NASDAQ: VRNS): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE:IBTA): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE:IBTA). The investigation
- 9mo agoIBTAITGRLFCRMOHNotice to Long-Term Shareholders of Ibatta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE:IBTA): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE:IBTA). The investigation
- 9mo agoCRWVITGRLFCRVRNSNotice to Long-Term Shareholders of CoreWeave, Inc. (NASDAQ: CRWV); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Varonis Systems, Inc. (NASDAQ: VRNS): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 22, 2026 (GLOBE NEWSWIRE) -- CoreWeave, Inc. (NASDAQ:CRWV) Grabar Law Office is investigating claims on behalf of shareholders of CoreWeave, Inc. (NASDAQ:CRWV). The investigation concerns
- 9mo agoIBTAITGRLFCRMOHNotice to Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and Molina Healthcare, Inc. (NYSE: MOH): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE:IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE:IBTA). The investigation concerns whether certain
- 9mo agoIBTALFCRMOHWBTNAttention Long-Term Shareholders of Ibotta, Inc. (NYSE: IBTA); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE:IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE:IBTA). The investigation concerns whether certain
- 9mo agoLFCRLifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore") a fully integrated contract development and manufacturing organization ("CDMO"), today announced that on January 14,
- 10mo agoITGRLFCRMOHWBTNAttention Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corp. (NYSE:ITGR): Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp. (NYSE:ITGR). The investigation
- 10mo agoITGRLFCRMOHWBTNImportant Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corp. (NYSE:ITGR): Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp. (NYSE:ITGR). The investigation
- 10mo agoITGRLFCRMOHSNPSImportant Notice to Long-Term Shareholders of Integer Holdings Corp, (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corp. (NYSE:ITGR): Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp. (NYSE:ITGR). The investigation
- 10mo agoCYTKLFCRMOHSNPSImportant Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation concerns
- 10mo agoINSPKMXLFCRWBTNImportant Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Lifecore Biomedical, Inc. (NASDAQ: LFCR); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE:KMX): Grabar Law Office is investigating claims on behalf of shareholders of CarMax, Inc. (NYSE:KMX). The investigation concerns whether certain
- 10mo agoCYTKLFCRMOHWBTNNotice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, Inc. (NASDAQ: LFCR); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ:CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ:CYTK). The investigation
- 10mo agoINSPITGRKMXLFCRImportant Notice to Long-Term Shareholders of CarMax, Inc. (NYSE: KMX); Inspire Medical Systems, Inc. (NYSE: INSP); Integer Holdings Corp. (NYSE: ITGR); Lifecore Biomedical, Inc. (NASDAQ: LFCR): Grabar Law Office Investigates Claims on Your BehalfGlobeNewswirePHILADELPHIA, Dec. 31, 2025 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE:KMX): Grabar Law Office is investigating claims on behalf of shareholders of CarMax, Inc. (NYSE:KMX). The investigation concerns whether certain
- 10mo agoLFCRNBILifecore Biomedical to be Added to Nasdaq Biotech IndexGlobeNewswireCHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that it has been
- 10mo agoLFCRLifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical CustomerGlobeNewswireAgreement Calls for Development Services and Tech Transfer in Preparation for Commercial Manufacturing of Injectable Pharmaceutical Product Partner's Program Size Positions it to Become a Top Five Commercial Customer
- 11mo agoLFCRLifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireCHASKA, Minn., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that the company
- 1y agoLFCRLifecore Biomedical to Participate in Upcoming Investor ConferencesGlobeNewswireCHASKA, Minn, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that the company
- 1y agoLFCRLifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate UpdateGlobeNewswire-- Recorded $31.1 Million in Revenue During the Three Months Ended September 30, 2025, Representing a 26% Increase From Comparable Period of 2024 -- -- Multiple New Programs Signed with New Customers -- -- Continued
- 1y agoLFCRLifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025GlobeNewswireCHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that it will
- 1y agoLFCRLifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical CompanyGlobeNewswireLifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major Multinational Organization in
- 1y agoLFCRLifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. MarketGlobeNewswireCHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), and
- 1y agoLFCRLifecore Biomedical to Participate at Upcoming Industry Conferences and EventsGlobeNewswireCHASKA, Minn., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that the company
- 1y agoLFCRLifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireCHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore") a fully integrated contract development and manufacturing organization ("CDMO"), today announced that on September